glp-1 receptors GLP-1/glucagon receptor co-agonism for treatment of obesity | Diabetologia Targeting GLP-1, GIP & GCG

GLP-1 medications start at low doses that are gradually increased, so full therapeutic effects develop over time as you reach the maintenance dose

Increasing skeletal muscle carnitine availability does not alter the adaptations to high-intensity interval training

By counteracting oxidative stress, it could potentially help minimize the appearance of wrinkles, fine lines, and other age-related skin changes

This approach leverages the complementary actions of insulin, which lowers fasting and post-absorptive blood sugar levels, and GLP-1 agonists, which target postprandial blood sugar levels (6)

E.DulnoanD.VoongK.AyisS.MangelisA.GorskaR.et al (2023)

Presented for research literature review only Tsuchida S et al